基于恶性验前概率评估FDG-PET/CT在孤立性肺结节中的性能:意大利回顾性多中心试验结果
该回顾性多中心试验分析了502例按恶性验前概率分层的孤立性肺结节患者的FDG-PET/CT,以病理和/或随访为标准,355例性质明确者中FDG摄取≥2分的灵敏度85.6%、特异度85.7%、准确率85.6%;中高危患者灵敏度和阳性预测值更高,低危患者特异度和阴性预测值更高;引入SUV比值可提高特异度。
要点
- FDG摄取≥2分时灵敏度85.6%、特异度85.7%、准确率85.6%。
- 中高危患者灵敏度和阳性预测值更高,低危患者特异度和阴性预测值更高(P<0.05)。
- 中高危患者纳入SUVmax/SUVmeanBP后特异度从85%和50%升至100%。
核心结论
- 视觉FDG-PET/CT在孤立性肺结节患者中性能可接受,但引入SUV比值后准确率提高,尤其在中高危恶性风险患者中。
研究设计与样本
- 意大利回顾性多中心试验,回顾性分析502例按恶性验前概率分层的孤立性肺结节患者的FDG-PET/CT。
- 以组织病理学和/或随访数据作为参考标准,355例结节性质明确(恶性或良性)者纳入分析。
主要发现
- 180例(36%)为恶性,175例(35%)为良性,147例(29%)性质不确定。
- FDG摄取≥2分时,灵敏度85.6%、特异度85.7%、阳性预测值86%、阴性预测值85.2%、准确率85.6%。
- 中危和高危患者灵敏度和阳性预测值更高(P<0.05),低危患者特异度和阴性预测值更高(P<0.05)。
- 受试者工作特征曲线分析中,SUVmax/SUVmeanBP界值1.56时灵敏度81%、特异度87%,SUVmax/SUVmeanL界值1.12时灵敏度81%、特异度86%。
- 中危和高危患者纳入SUVmax/SUVmeanBP后,特异度从85%和50%升至100%。
关键数值与推荐
- FDG摄取采用4点评分系统评估,≥2分为阳性。
- 半定量分析采用结节SUVmax与纵隔血池SUVmean的比值(SUVmax/SUVmeanBP)及与肝脏SUVmean的比值(SUVmax/SUVmeanL)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to determine the performance of 18F-FDG-PET/CT in patients with solitary pulmonary nodule (SPN), stratifying the risk according to the likelihood of pulmonary malignancy. METHODS: FDG-PET/CT of 502 patients, stratified for pre-test cancer risk, were retrospectively analyzed. FDG uptake in SPN was assessed by a 4-point scoring system and semiquantitative analysis using the ratio between SUVmax in SPN and SUVmean in mediastinal blood pool (BP) and between SUVmax in SPN and SUVmean in liver (L). Histopathology and/or follow-up data were used as standard of reference. RESULTS: SPN was malignant in 180 (36%) patients, benign in 175 (35%), and indeterminate in 147 (29%). The 355 patients with a definitive SPN nature (malignant or benign) were considered for the analysis. Considering FDG uptake ≥ 2, sensitivity, specificity, positive (PPV) and negative (NPV) predictive values, and accuracy were 85.6%, 85.7%, 86%, 85.2%, and 85.6% respectively. Sensitivity and PPV were higher (P < 0.05) in intermediate and high-risk patients, while specificity and NPV were higher (P < 0.05) in low-risk patients. On receiver operating characteristic curve analysis, the cut-offs for better discrimination between benign and malignant SPN were 1.56 (sensitivity 81% and specificity 87%) and 1.12 (sensitivity 81% and specificity 86%) for SUVmax/SUVmeanBP and SUVmax/SUVmeanL respectively. In intermediate and high-risk patients, including the SUVmax/SUVmeanBP, the specificity shifted from 85% and 50% to 100%. CONCLUSION: Visual FDG-PET/CT has an acceptable performance in patients with SPN, but accuracy improves when SUVratios are considered, particularly in patients with intermediate and high risk of malignancy.
引用
- Evangelista L, Cuocolo A, Pace L, et al. Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial. Eur J Nucl Med Mol Imaging. 2018. PMID: 29736699. doi:10.1007/s00259-018-4016-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。